KR20110084513A - 중증 집중치료 환자를 인공적으로 영양공급하기 위한 지방 유제 - Google Patents

중증 집중치료 환자를 인공적으로 영양공급하기 위한 지방 유제 Download PDF

Info

Publication number
KR20110084513A
KR20110084513A KR1020117010418A KR20117010418A KR20110084513A KR 20110084513 A KR20110084513 A KR 20110084513A KR 1020117010418 A KR1020117010418 A KR 1020117010418A KR 20117010418 A KR20117010418 A KR 20117010418A KR 20110084513 A KR20110084513 A KR 20110084513A
Authority
KR
South Korea
Prior art keywords
acid
triglycerides
fatty acids
triglyceride
omega
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020117010418A
Other languages
English (en)
Korean (ko)
Inventor
미하엘 볼
Original Assignee
베. 브라운 멜중엔 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41581163&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20110084513(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 베. 브라운 멜중엔 악티엔게젤샤프트 filed Critical 베. 브라운 멜중엔 악티엔게젤샤프트
Publication of KR20110084513A publication Critical patent/KR20110084513A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020117010418A 2008-11-18 2009-11-09 중증 집중치료 환자를 인공적으로 영양공급하기 위한 지방 유제 Ceased KR20110084513A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008057867.3 2008-11-18
DE102008057867A DE102008057867A1 (de) 2008-11-18 2008-11-18 Fettemulsion zur künstlichen Ernährung von schwerkranken Intensivpatienten

Publications (1)

Publication Number Publication Date
KR20110084513A true KR20110084513A (ko) 2011-07-25

Family

ID=41581163

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117010418A Ceased KR20110084513A (ko) 2008-11-18 2009-11-09 중증 집중치료 환자를 인공적으로 영양공급하기 위한 지방 유제

Country Status (12)

Country Link
US (2) US20110207819A1 (cg-RX-API-DMAC7.html)
EP (1) EP2355813B1 (cg-RX-API-DMAC7.html)
JP (1) JP2012509292A (cg-RX-API-DMAC7.html)
KR (1) KR20110084513A (cg-RX-API-DMAC7.html)
CN (1) CN102215839B (cg-RX-API-DMAC7.html)
BR (1) BRPI0921917B8 (cg-RX-API-DMAC7.html)
CA (1) CA2739390C (cg-RX-API-DMAC7.html)
DE (1) DE102008057867A1 (cg-RX-API-DMAC7.html)
ES (1) ES2561207T3 (cg-RX-API-DMAC7.html)
MX (1) MX338223B (cg-RX-API-DMAC7.html)
RU (1) RU2528108C2 (cg-RX-API-DMAC7.html)
WO (1) WO2010057804A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009013914B4 (de) * 2009-03-19 2011-05-05 Bruker Daltonik Gmbh Kalibriersubstanzen für Atmosphärendruck-Ionenquellen
AU2012211854A1 (en) * 2011-01-31 2013-08-08 Nagoya Industrial Science Research Institute Prophylactic or therapeutic drug for peripheral neuropathy caused by anticancer agent
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
CN106900888B (zh) * 2015-12-23 2021-12-24 丰益(上海)生物技术研发中心有限公司 含有奇数碳脂肪酸结构脂的油脂组合物及其应用
NZ749389A (en) * 2016-06-08 2022-12-23 Sunregen Healthcare Ag Lipids with odd number of carbon atoms and their use as pharmaceutical composition or nutritional supplement
CN109602704A (zh) * 2019-01-23 2019-04-12 广东嘉博制药有限公司 丁酸氯维地平脂肪乳注射液及其制备工艺
CN110326789A (zh) * 2019-06-11 2019-10-15 上海互众药业有限公司 一种脂肪乳食品补充液及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515174A1 (fr) 1981-10-23 1983-04-29 Roussel Uclaf Nouveaux triglycerides, procede de preparation et d'applications en dietetique et en therapeutique
US4526902A (en) 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
DE3721137A1 (de) 1987-06-26 1989-01-05 Dietl Hans Fettemulsion zur intravenoesen anwendung
DE3722540A1 (de) 1987-07-08 1989-01-19 Fresenius Ag Fettemulsion, verfahren zu ihrer herstellung und ihre verwendung
DE3734147C2 (de) * 1987-10-09 1998-10-29 Braun Melsungen Ag Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung
AU682894B2 (en) * 1993-10-28 1997-10-23 Institut National De La Recherche Agronomique Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man
RU2155612C2 (ru) * 1997-01-30 2000-09-10 Скрипченко Наталия Викторовна Способ лечения острых инфекционных заболеваний периферической нервной системы
US6740679B1 (en) 1999-02-05 2004-05-25 Baylor University Medical Center Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid
US20030162833A1 (en) * 2001-08-01 2003-08-28 Roe Charles R. Fatty acid treatment for cardiac patients
CA2361070C (en) * 1999-02-05 2012-04-17 Baylor Research Institute Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid
EA006881B1 (ru) * 2001-10-11 2006-04-28 Апплайд Резеч Системз Арс Холдинг Н.В. ПРИМЕНЕНИЕ АКТИВАТОРОВ gp130 ПРИ ДИАБЕТИЧЕСКОЙ НЕВРОПАТИИ
EP1628622A4 (en) * 2003-05-20 2008-12-17 Baylor Res Inst FIVE AND FIFTH CARBON FATTY ACIDS FOR THE TREATMENT OF METABOLISM DISORDERS AND AS FOOD SUPPLEMENTS
CA2573054C (en) * 2004-07-02 2012-10-09 Baylor Research Institute Glycogen or polysaccharide storage disease treatment method
EP1723944B1 (de) * 2005-02-16 2007-04-04 Dr. Streatmans Chemische Produktion GmbH Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an chemischen UV-Filtern und Triheptanonin
JP2011502950A (ja) 2006-09-26 2011-01-27 ベイラー リサーチ インスティテュート 栄養センサー

Also Published As

Publication number Publication date
US20110207819A1 (en) 2011-08-25
DE102008057867A1 (de) 2010-05-20
WO2010057804A1 (de) 2010-05-27
EP2355813B1 (de) 2015-11-04
MX338223B (es) 2016-04-08
BRPI0921917B1 (pt) 2020-08-25
CA2739390C (en) 2016-05-03
BRPI0921917A2 (pt) 2015-12-29
RU2011124887A (ru) 2012-12-27
MX2011005201A (es) 2011-06-01
RU2528108C2 (ru) 2014-09-10
JP2012509292A (ja) 2012-04-19
BRPI0921917B8 (pt) 2021-05-25
CN102215839B (zh) 2016-08-24
US20160051506A1 (en) 2016-02-25
ES2561207T3 (es) 2016-02-25
EP2355813A1 (de) 2011-08-17
CN102215839A (zh) 2011-10-12
CA2739390A1 (en) 2010-05-27

Similar Documents

Publication Publication Date Title
US8410181B2 (en) Omega-3 diglyceride emulsions
CA2739390C (en) Fat emulsion for artificially feeding seriously ill intensive care patients
CN102348469B (zh) 富含omega-3的水包鱼油非口服营养乳状液
JP6722118B2 (ja) ω３脂肪酸の自己乳化組成物
JP5313343B2 (ja) ω３脂肪酸の自己乳化組成物
EP2230942A1 (en) Lipid mixture for infant nutrition
EP3099289B1 (en) Composition comprising epa and dha triglycerides for parenteral administration
US9861605B2 (en) Enriched injectable emulsion containing selected fatty acid triglycerides
CN105939706A (zh) 用于肠胃外给药的包含epa乙酯和dha乙酯的组合物
DE102009003980A1 (de) Propofol in triheptanoinhaltiger Trägeremulsion
KR102925351B1 (ko) 오메가 지방산을 포함하는 약학 조성물 및 이를 포함하는 수액제제
EP3579829B1 (en) Long-term efficacy of liver disease treatment with epa and dha

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20110506

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20141107

Comment text: Request for Examination of Application

A302 Request for accelerated examination
PA0302 Request for accelerated examination

Patent event date: 20150930

Patent event code: PA03022R01D

Comment text: Request for Accelerated Examination

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20151201

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20160205

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20151201

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I